Journal of the Neurological Sciences
Volume 287, Issue 1 , Pages 79-83 , 15 December 2009

Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system

  • Paulo Pereira Christo

      Affiliations

    • Neurology Unit, University Hospital, Federal University of Minas Gerais, Belo Horizonte, Brazil
    • Eduardo de Menezes Hospital, Belo Horizonte, Brazil
    • ,
  • Márcia de Carvalho Vilela

      Affiliations

    • Group of Neuroimmunology, Laboratory of Immunopharmacology, Institute of Biological Sciences and School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil
    • ,
  • Thales Lage Bretas

      Affiliations

    • Group of Neuroimmunology, Laboratory of Immunopharmacology, Institute of Biological Sciences and School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil
    • ,
  • Renan Barros Domingues

      Affiliations

    • Department of Pathology, Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM), Brazil
    • ,
  • Dirceu Bartolomeu Greco

      Affiliations

    • Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil
    • ,
  • José Antonio Livramento

      Affiliations

    • Department of Neurology, School of Medicine, University of São Paulo, São Paulo, Brazil
    • ,
  • Antonio Lucio Teixeira

      Affiliations

    • Neurology Unit, University Hospital, Federal University of Minas Gerais, Belo Horizonte, Brazil
    • Group of Neuroimmunology, Laboratory of Immunopharmacology, Institute of Biological Sciences and School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil
    • Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil
    • Corresponding Author InformationCorresponding author. Laboratório de Imunofarmacologia, Bloco O4 Sala 202, Departamento de Bioquímica e Imunologia (ICB), Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627, Pampulha, 31270-901 Belo Horizonte, Brazil. Tel./fax: +55 31 3409 2651.

Received 9 April 2009 ,Revised 14 August 2009 ,Accepted 3 September 2009.

References 

  1. Charo IF, Ransohoff RM. The many roles of chemokines and chemokines receptors in inflammation. N Engl J Med. 2006;354:610–621
  2. Mackay CR. Chemokines: immunology's high impact factors. Nat Immunol. 2001;2:95–101
  3. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000;95:3032–3043
  4. Moreira MA, Tilbery CP, Monteiro LP, Teixeira MM, Teixeira AL. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis. Acta Neurol Scand. 2006;114:109–113
  5. Teixeira AL, Cardoso F, Souza AL, Teixeira MM. Increased serum concentrations of monokine induced by interferon-gamma/CXCL9 and interferon-gamma-inducible protein 10/CXCL-10 in Sydenham's chorea patients. J Neuroimmunol. 2004;150:157–162
  6. Ransohoff RM. The chemokine system in neuroinflammation: an update. J Infect Dis. 2002;86(suppl 2):S152–S156
  7. Biber K, Zuurman MW, Dijkstra IN, Boddeke HW. Chemokines in the brain: neuroimmunology and beyond. Curr Opin Pharmacol. 2002;2:63–68
  8. Adler MW, Rogers TJ. Are chemokines the third major system in the brain?. J Leukoc Biol. 2005;78:1204–1209
  9. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol. 1998;44:831–835
  10. Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology. 2004;63:2084–2090
  11. Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol. 2007;64:97–102
  12. Cinque P, Bestetti A, Marenzi R, Sala S, Gisslen M, Hagberg L, et al. Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection. J Neuroimmunol. 2005;168:154–163
  13. Marzocchetti A, Cingolani A, Giambenedetto SD, Ammassari A, Giancola ML, Cauda R, et al. Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome–associated progressive multifocal leukoencephalopathy (PML). J Neurovirol. 2005;11:219–224
  14. Christo PP, Greco DB, Aleixo AW, Livramento JA. HIV-1 RNA levels in cerebrospinal fluid and plasma and their correlation with opportunistic neurological diseases in a Brazilian AIDS reference hospital. Arq Neuropsiquiatr. 2005;63:907–913
  15. Oliveira JF, Greco DB, Oliveira GC, Christo PP, Guimarães MD, Oliveira RC. Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience. Rev Soc Bras Med Trop. 2006;39:146–151
  16. Christo PP, Greco DB, Aleixo AW, Livramento JA. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era. BMC Infect Dis. 2007;7:147
  17. Guerini FR, Delbue S, Zanzottera M, Agliardi C, Saresella M, Mancuso R, et al. Analysis of CCR5, CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathy. Biomed Pharmacother. 2008;62:26–30
  18. Contini C. Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient. Parassitologia. 2008;50:45–50
  19. Bicanic T, Harrison TS. Cryptococcal meningitis. Br Med Bull. 2005;72:99–118
  20. Uicker WC, Doyle HA, McCracken JP, Langlois M, Buchanan KL. Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans. Med Mycol. 2005;43:27–38
  21. Siddiqui AA, Brouwer AE, Wuthiekanun V, Jaffar S, Shattock R, Irving D, et al. IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J Immunol. 2005;174:1746–1750
  22. Brenier-Pinchart MP, Blanc-Gonnet E, Marche PN, Berger F, Durand F, Ambroise-Thomas P, et al. Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii: monocyte chemotactic protein-1 secretion and chemokine expression in vitro. Acta Neuropathol. 2004;107:245–249
  23. Kolb SA, Sporer B, Lahrtz F, Koedel U, Pfister HW, Fontana A. Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J Neuroimmunol. 1999;93:172–181
  24. Gisolf EH, van Praag RM, Jurriaans S, Portegies P, Goudsmit J, Danner SA, et al. Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;25:426–433
  25. Monteiro de Almeida S, Letendre S, Zimmerman J, Lazzaretto D, McCutchan A, Ellis R. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. J Neuroimmunol. 2005;169:144–152
  26. Monteiro de Almeida S, Letendre S, Zimmerman J. Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy. J Neuroimmunol. 2006;179:180–185
  27. Letendre SL, Lanier ER, McCutchan JA. Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1. J Infect Dis. 1999;180:310–319
  28. McCoig C, Castrejón MM, Saavedra-Lozano J, Castaño E, Báez C, Lanier ER, et al. Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23:114–118

PII: S0022-510X(09)00844-2

doi: 10.1016/j.jns.2009.09.002

Journal of the Neurological Sciences
Volume 287, Issue 1 , Pages 79-83 , 15 December 2009

Article Tools

* Image Usage & Resolution